New Clot-Busting device could change stroke care
NCT ID NCT06733246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called Ceretrieve that is designed to remove blood clots from brain arteries in people having a severe stroke. About 132 participants will be treated within 24 hours of symptoms starting. The goal is to see if the device can safely restore blood flow and improve outcomes compared to existing devices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ceretrieve neuro-thrombectomy aspiration catheter (a device to remove blood clots from brain arteries)
What this could lead to
If successful, this device could offer a safe and effective way to restore blood flow in stroke patients, potentially reducing disability and improving recovery.
What could go wrong
This is an early-stage study with only 132 participants, and it compares results to past studies rather than a direct comparison group. There is a risk of bleeding in the brain or the device not working as well as expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- THUNDER Stroke Study: Penumbra System with Thund NCT05437055
- Stroke Alarm Efficacy Trial (NCT06315192)
- IMPROVE-II: FAST Model for Stroke Reperfusion (NCT06330051)
- Virtual Reality Rehab for Stroke Recovery - NCT07674329
- Endovascular Therapy for Basilar Artery Stroke (NCT07672795)
- Oropharyngeal Suction Tube for Stroke Pneumonia NCT07647666
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heidelberg University Hospital
RECRUITINGHeidelberg, 69120, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••